Brief: Promore Pharma Modifies Its Phase III Trial Of Pxl01 And Expands The Number Of Clinics In The Study

PMD Device Solutions AB

01/02/2019 08:47

Feb 1 (Reuters) - Promore Pharma AB  PROMO.ST :
    * PROMORE PHARMA MODIFIES ITS PHASE III TRIAL OF PXL01 AND EXPANDS THE NUMBER OF CLINICS IN
THE
STUDY
    * ADJUSTMENTS MEAN THAT PROVISION OF INVESTIGATIONAL MEDICINAL PRODUCT IS DELAYED
    * TO MINIMIZE OVERALL DELAY, COMPANY INTENDS TO INCREASE NUMBER OF CLINICS IN ORDER TO
ENABLE
FASTER RECRUITMENT OF PATIENTS TO STUDY
    * MAKING ADJUSTMENTS TO MANUFACTURING CHAIN OF INVESTIGATIONAL MEDICINAL PRODUCT FOR
COMPANY'S
CLINICAL PHASE III STUDY

Source text for Eikon:  ID:nWkrc2YHrV 
Further company coverage:  PROMO.ST 

 (Gdynia Newsroom)
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))